Abstract

The volume of knowledge that the scientific community has compiled about SARS-CoV-2 and amyloid beta peptide is scarce, but it is growing every day. The interaction between the virus and the amyloid beta peptide is poorly understood and some data are unclear. The long-term consequences of SARS-CoV-2 infection on human health remain uncertain at this time. The present work provides a discussion about the association between the amyloid beta peptide and COVID-19.